Sector
PharmaceuticalsOpen
₹22.41Prev. Close
₹22.41Turnover(Lac.)
₹7.74Day's High
₹22.41Day's Low
₹21.2952 Week's High
₹23.8552 Week's Low
₹6.4Book Value
₹15.6Face Value
₹10Mkt Cap (₹ Cr.)
51.7P/E
49.8EPS
0.45Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 24.05 | 11.97 | 0.04 | 0.04 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 13.47 | 12.39 | 1.7 | 0.54 |
Net Worth | 37.52 | 24.36 | 1.74 | 0.58 |
Minority Interest |
No Record Found
No Record Found
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,766.2 | 134.52 | 4,23,770.54 | 1,181.05 | 0.76 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,958.35 | 76.3 | 1,58,175.47 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,486.75 | 25.8 | 1,20,075.94 | 1,438.15 | 0.87 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,183 | 59.05 | 1,07,722.35 | 485 | 0.88 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,434.1 | 51.93 | 1,00,425.74 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Keyur Shah
Chairperson
Dipna Shah
Independent Director
Nandish Jani
Additional Director
Parin Bhavsar
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Dipna Pharmachem Ltd
Summary
Dipan Pharmachem Private Limited was incorporated on July 19, 2011. Subsequently, the Company name was changed to Dipna Pharmachem Private Limited on March 29, 2012. Later on, it was converted from Private Limited to Public Limited and the name of Company was changed to Dipna Pharmachem Limited vide fresh Certificate of Incorporation issued by Registrar of Companies, Ahmedabad dated May 25, 2022. Mr. Keyur Shah, being the Promoter, the Company is engaged in trading and distribution of pharmaceutical raw material and chemical formulation products, also known as APIs (Active Pharmaceutical Ingredients). Presently, its product portfolio comprises of 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovasculars, Anti - Bactaria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone, other etc. Being a trading and distribution company, it has a pan India market for products. In FY 2022, the Company started trading of chemicals in Ahmedabad.In August 2022, Company made a fresh issue by raising funds through IPO aggregating to Rs 15.2 Cr and by issuing 40,02,000 equity shares of Rs 10/- each.
Read More
The Dipna Pharmachem Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹21.5 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dipna Pharmachem Ltd is ₹51.70 Cr. as of 09 May ‘25
The PE and PB ratios of Dipna Pharmachem Ltd is 49.8 and 1.44 as of 09 May ‘25
The 52-week high/low is the highest and lowest price at which a Dipna Pharmachem Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Dipna Pharmachem Ltd is ₹6.4 and ₹23.85 as of 09 May ‘25
Dipna Pharmachem Ltd's CAGR for 5 Years at N/I%, 3 Years at -6.53%, 1 Year at 170.98%, 6 Month at 204.48%, 3 Month at 46.28% and 1 Month at 47.92%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.